LncRNA H19/Runx2 axis promotes VSMCs transition via MAPK pathway

Area of Science:

• Cardiovascular Biology
• Molecular Biology
• Epigenetics

Background:

• Arterial calcification (AC) is a complex process often driven by the osteoblastic transition of vascular smooth muscle cells (VSMCs).
• Long noncoding RNAs (lncRNAs) are emerging as critical regulators in various biological processes, including cellular differentiation and disease.
• The role of lncRNA H19 in VSMC transition and AC remains incompletely understood.

Purpose of the Study:

• To investigate the role of lncRNA H19 in VSMC phenotypic transition.
• To elucidate the molecular mechanisms by which lncRNA H19 influences AC.
• To explore the potential of lncRNA H19 as a biomarker or therapeutic target for AC.

Main Methods:

• VSMCs were induced to calcify using β-glycerophosphate.
• Quantitative PCR (qPCR) and Western Blot were employed to assess gene and protein expression levels.
• Small interfering RNA (siRNA) was used to knockdown lncRNA H19 expression.
• Signaling pathway analysis focused on MAPK pathways (p38 and ERK1/2).

Main Results:

• lncRNA H19 expression was significantly upregulated in calcified VSMCs compared to normal VSMCs.
• Knockdown of lncRNA H19 reduced VSMC calcification and the expression of key osteogenic markers like Runx2 and OSX.
• lncRNA H19 was found to promote VSMC calcification through the activation of p38 MAPK and ERK1/2 signaling pathways.

Conclusions:

• The lncRNA H19/Runx2 axis plays a crucial role in promoting VSMC transition and arterial calcification via the MAPK pathway.
• lncRNA H19 represents a novel regulator in the context of AC.
• These findings suggest lncRNA H19 could serve as a potential early diagnostic marker and therapeutic target for arterial calcification.